Patel, K., Crombie, J., Phillips, T., Dickinson, M., Eyre, T., Cheah, C., Schuster, S., Shah, N., Lenz, G., Sehn, L., Tsai, D., Johnston, E., Chapman, S., Han, H., Balbas, M., Leow, C. C., Salles, G. (2025). A first-in-human Phase 1 trial of LY4152199, a B-cell activation factor receptor (BAFF-R) T-cell engager bispecific antibody, in patients with previously treated B-cell malignancies (BAF_FRontier-1 Trial in Progress). Blood. https://doi.org/10.1182/blood-2025-5524